Figure 5.
EGb761 suppressed the growth of orthotopic tumors in an orthotopic transplantation model. Orthotopic transplantation mice were randomly divided into 2 groups for treatment – intraperitoneal injection of EGb761 (40 mg/kg) or saline (0.9%) – twice a week. (A) The orthotopic transplantation nude mice in EGb761 and control groups. (B) The size of orthotopic tumors in transplanted nude mice. ** P<0.01 vs. control group.